<SEC-DOCUMENT>0000919574-25-005433.txt : 20250902
<SEC-HEADER>0000919574-25-005433.hdr.sgml : 20250902
<ACCEPTANCE-DATETIME>20250902080023
ACCESSION NUMBER:		0000919574-25-005433
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20250902
DATE AS OF CHANGE:		20250902

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STAAR SURGICAL CO
		CENTRAL INDEX KEY:			0000718937
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				953797439
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1227

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-36017
		FILM NUMBER:		251282991

	BUSINESS ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016
		BUSINESS PHONE:		6263037902

	MAIL ADDRESS:	
		STREET 1:		1911 WALKER AVE
		CITY:			MONROVIA
		STATE:			CA
		ZIP:			91016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STAAR SURGICAL COMPANY
		DATE OF NAME CHANGE:	19920703

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BROADWOOD PARTNERS, L.P.
		CENTRAL INDEX KEY:			0001278386
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		BROADWOOD CAPITAL INC.
		STREET 2:		156 WEST 56TH STREET, 3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		212-508-5735

	MAIL ADDRESS:	
		STREET 1:		BROADWOOD CAPITAL INC.
		STREET 2:		156 WEST 56TH STREET, 3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BROADWOOD PARTNERS LP
		DATE OF NAME CHANGE:	20040202
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: BROADWOOD PARTNERS, L.P. -->
          <cik>0001278386</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>36</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.01 per share</securitiesClassTitle>
      <dateOfEvent>09/02/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0000718937</issuerCIK>
        <issuerCUSIP>852312305</issuerCUSIP>
        <issuerName>STAAR SURGICAL CO</issuerName>
        <address>
          <com:street1>25510 Commercentre Drive</com:street1>
          <com:city>Lake Forest</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92630</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Neal C. Bradsher</personName>
          <personPhoneNum>(212) 508-5735</personPhoneNum>
          <personAddress>
            <com:street1>c/o Broadwood Capital, Inc.</com:street1>
            <com:street2>156 West 56th Street, 3rd Floor</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10019</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001278386</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Broadwood Partners, L.P.</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>WC</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>13519491.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>13519491.00</sharedDispositivePower>
        <aggregateAmountOwned>13519491.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>27.3</percentOfClass>
        <typeOfReportingPerson>PN</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001278387</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Broadwood Capital, Inc.</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>NY</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>13519491.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>13519491.00</sharedDispositivePower>
        <aggregateAmountOwned>13519491.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>27.3</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
        <typeOfReportingPerson>IA</typeOfReportingPerson>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonCIK>0001278388</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Neal C. Bradsher</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>AF</fundType>
        <fundType>PF</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X1</citizenshipOrOrganization>
        <soleVotingPower>25900.00</soleVotingPower>
        <sharedVotingPower>13519491.00</sharedVotingPower>
        <soleDispositivePower>25900.00</soleDispositivePower>
        <sharedDispositivePower>13519491.00</sharedDispositivePower>
        <aggregateAmountOwned>13545391.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>27.3</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <typeOfReportingPerson>HC</typeOfReportingPerson>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Stock, par value $0.01 per share</securityTitle>
        <issuerName>STAAR SURGICAL CO</issuerName>
        <issuerPrincipalAddress>
          <com:street1>25510 Commercentre Drive</com:street1>
          <com:city>Lake Forest</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92630</com:zipCode>
        </issuerPrincipalAddress>
      </item1>
      <item2>
        <filingPersonName>(a), (f) The persons filing this statement are: (i) Broadwood Partners, L.P., a Delaware limited partnership ("Broadwood Partners"); (ii) Broadwood Capital, Inc., a New York corporation ("Broadwood Capital"); and (iii) Neal C. Bradsher, a United States citizen ("Mr. Bradsher", and collectively with Broadwood Partners and Broadwood Capital, the "Reporting Persons").</filingPersonName>
        <principalBusinessAddress>(b), (c) Broadwood Capital is an investment adviser registered with the Securities and Exchange Commission that is principally engaged in the business of providing investment advisory services.  Broadwood Partners is a pooled investment vehicle that is principally engaged in the business of investing its assets in securities.  Broadwood Capital serves as the general partner of Broadwood Partners.  Neal Bradsher is the President of Broadwood Capital.  The principal business address of the Reporting Persons is: c/o Broadwood Capital, Inc., 156 West 56th Street, 3rd Floor, New York, New York 10019.</principalBusinessAddress>
        <hasBeenConvicted>None of the Reporting Persons have, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>
        <convictionDescription>None of the Reporting Persons have, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.</convictionDescription>
      </item2>
      <item3>
        <fundsSource>The funds for the purchase of the 13,519,491 Shares beneficially owned by Broadwood Partners came from its working capital.  No borrowed funds were used to purchase the Shares, other than any borrowed funds used for working capital purposes in the ordinary course of business.

The funds for the purchase of the 13,519,491 Shares beneficially owned by Broadwood Capital came from the working capital of Broadwood Partners, which is the direct owner of the Shares.  No borrowed funds were used to purchase the Shares, other than any borrowed funds used for working capital purposes in the ordinary course of business.

The funds for the purchase of the 13,545,391 Shares beneficially owned by Mr. Bradsher came from his personal funds and the working capital of Broadwood Partners.  No borrowed funds were used to purchase the Shares, other than any borrowed funds used for working capital purposes in the ordinary course of business.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>On August 5, 2025, the Issuer announced that it had entered into a definitive merger agreement through which Alcon will acquire the Issuer. The Reporting Persons presently intend to vote against the merger and have issued a press release on this topic today that is attached as Exhibit B.

The Reporting Persons also continue to explore strategic alternatives to the merger, including through contact with possible alternative strategic and financial partners for the Issuer.

The Reporting Persons intend to review their investment in the Issuer on a continuing basis, taking into account the merger agreement. Depending on various factors including, without limitation, the Issuer's financial position, the terms of the merger agreement, a potential superior offer, the price levels of the Shares, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may take such actions with respect to their investment in the Issuer as they deem appropriate. In that regard, the Reporting Persons have been and may continue to be in contact with members of the Issuer's management, Board, other significant shareholders, potential alternative strategic and financial partners for the Issuer, and others regarding alternatives that could be employed to create additional shareholder value, whether in the near or long term.

Except as otherwise set forth herein, the Reporting Persons do not have any present plans or proposals which would relate to, or result in, the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D. However, subject to market conditions and in compliance with applicable securities laws, the Reporting Persons reserve the right, at a later date, to effect one or more of such changes or transactions in the number of Shares they may be deemed to beneficially own in open-market or privately negotiated transactions, on such terms and at such times as the Reporting Persons may deem advisable.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>(a)-(d) As of the date hereof, Broadwood Partners may be deemed to be the beneficial owner of 13,519,491 Shares, constituting 27.3% of the Shares, based upon 49,553,035 Shares outstanding as of the date hereof.  Broadwood Partners has the sole power to vote or direct the vote of 0 Shares and the shared power to vote or direct the vote of 13,519,491 Shares.  Broadwood Partners has sole power to dispose or direct the disposition of 0 Shares and the shared power to dispose or direct the disposition 13,519,491 Shares.

As of the date hereof, Broadwood Capital may be deemed to be the beneficial owner of 13,519,491 Shares, constituting 27.3% of the Shares, based upon 49,553,035 Shares outstanding as of the date hereof.  Broadwood Capital has the sole power to vote or direct the vote of 0 Shares and the shared power to vote or direct the vote of 13,519,491 Shares.  Broadwood Capital has sole power to dispose or direct the disposition of 0 Shares and the shared power to dispose or direct the disposition 13,519,491 Shares.

As of the date hereof, Mr. Bradsher may be deemed to be the beneficial owner of 13,545,391 Shares, constituting 27.3% of the Shares, based upon  49,553,035 Shares outstanding as of the date hereof.  Mr. Bradsher has the sole power to vote or direct the vote of 25,900 Shares and the shared power to vote or direct the vote of 13,519,491 Shares.  Mr. Bradsher has sole power to dispose or direct the disposition of 25,900 Shares and the shared power to dispose or direct the disposition 13,519,491 Shares.

There have been no transactions in the Shares by the Reporting Persons during the past sixty days.</percentageOfClassSecurities>
        <date5PercentOwnership>N/A</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>The information set forth in Item 4 above is incorporated by reference in its entirety in this Item 6.  The Reporting Persons do not have any contract, arrangement, understanding or relationship with any person with respect to securities of the Issuer that is not described herein and/or in a previous Schedule 13D filed by the Reporting Persons in respect of the Issuer.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Exhibit A:  Joint Filing Agreement

Exhibit B: Press Release</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Broadwood Partners, L.P.</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Neal C. Bradsher*</signature>
          <title>Neal C. Bradsher / President of Broadwood Capital, Inc.</title>
          <date>09/02/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Broadwood Capital, Inc.</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Neal C. Bradsher*</signature>
          <title>Neal C. Bradsher / President</title>
          <date>09/02/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Neal C. Bradsher</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Neal C. Bradsher*</signature>
          <title>Neal C. Bradsher</title>
          <date>09/02/2025</date>
        </signatureDetails>
      </signaturePerson>
      <commentText>* This Reporting Person disclaims beneficial ownership over the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.</commentText>
    </signatureInfo>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>d11974491_ex99-a.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">Exhibit A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><U>JOINT FILING AGREEMENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The undersigned agree that
this Amendment No. 36 to Schedule 13D, dated September 2, 2025, relating to the Common Stock, par value $0.01 per share, of STAAR Surgical
Company shall be filed on behalf of the undersigned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Dated:&nbsp;&nbsp;September 2, 2025</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="text-transform: uppercase">Broadwood Partners, L.P.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 8%; padding-right: 5.4pt; padding-left: 5.4pt">By:</TD>
    <TD STYLE="width: 42%; padding-right: 5.4pt; padding-left: 5.4pt">Broadwood Capital, Inc.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">/s/ Neal C. Bradsher</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Name:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Neal C. Bradsher</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Title:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">President</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="text-transform: uppercase">Broadwood Capital, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">/s/ Neal C. Bradsher</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Name:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Neal C. Bradsher</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Title:</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">President</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">/s/ Neal C. Bradsher </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="text-transform: uppercase">Neal C. Bradsher</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>3
<FILENAME>d11974491_ex99-b.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt; text-align: right">Exhibit B</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt"><B>Broadwood Announces Intent to Vote Against Acquisition of STAAR
Surgical by Alcon </B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt"><B>FOR IMMEDIATE RELEASE </B></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt"><B>(New York, NY &ndash; September 2, 2025) </B><FONT STYLE="color: #202020">&ndash;
</FONT><FONT STYLE="color: #111111">Broadwood Partners, L.P. and its affiliates (together, &ldquo;Broadwood&rdquo;) currently intend to
vote against the proposed acquisition of STAAR Surgical Company by Alcon Inc. Broadwood is STAAR&rsquo;s largest shareholder, owning 27.3%
of STAAR&rsquo;s common shares outstanding. Broadwood has owned STAAR shares for over 30 years, has been the company&rsquo;s largest shareholder
since 2007, and has long been one of STAAR&rsquo;s largest and most supportive stockholders, including by providing capital to the company
on various occasions. Broadwood continues to believe in the superiority of STAAR&rsquo;s proprietary technology, its large global growth
potential, and its ability to again become a highly profitable company. </FONT></P>

<P STYLE="color: #111111; font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt">Unfortunately, after reviewing the preliminary
merger proxy statement that STAAR filed last Friday, and in particular the history of negotiations that was disclosed in the preliminary
proxy, Broadwood believes the transaction suffers from multiple process and valuation deficiencies. Further, Broadwood has been disappointed
in the choices that STAAR&rsquo;s Board of Directors has made under the influence of its current advisers. These choices include not only
the choice to sell the company without pursuing an adequate sale process, but also intransigence with respect to the process regarding
Broadwood&rsquo;s books and records demand. This demand has not resulted in the production of any documents despite the passage of 24
days since the demand was made.</P>

<P STYLE="color: #111111; font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt">The Background of the Merger in the preliminary
proxy discloses multiple important facts. First, Alcon previously offered $55.00 per share and a $7.00 contingent value right for STAAR
in October 2024 &mdash; a price far above the current offer. Alcon subsequently withdrew its offer shortly before STAAR reported that
it faced inventory management challenges. However, those challenges have now been addressed, and STAAR has improved its cost discipline,
providing a path to a sharp rebound in its revenue and profits in coming quarters. Broadwood is concerned that stockholders are now being
asked to accept inferior terms despite the fact that the challenges that followed Alcon&rsquo;s initial bid have been substantially resolved.</P>

<P STYLE="color: #111111; font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt">Second, the preliminary proxy indicates that there
was no meaningful market check. The proxy acknowledges that two additional parties &mdash; Party A and Party B &mdash; expressed interest
in a potential transaction. However, neither was provided sufficient time to submit a proposal, and neither STAAR nor its advisers conducted
any formal outreach to solicit interest from other potential bidders. Based on its ongoing discussions with multiple strategic and financial
parties, Broadwood believes that far better value-creating alternatives than the Alcon acquisition offer would have been available to
the STAAR Board and STAAR&rsquo;s shareholders if a proper sale process had been pursued. Such alternatives could have included an acquisition
of STAAR at a higher value, or a sale of part of STAAR at a high value, or other alternatives.</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt; color: #111111">Third, STAAR&rsquo;s second quarter results, which
were not released until after the merger agreement was executed and announced, reflected the progress by STAAR in reducing its cost structure
and resolving the temporary challenges that resulted in the sharp decline in its stock price in late 2024 and early 2025. Broadwood believes
that by securing deal execution before those results became public, Alcon was effectively able to lock in the transaction at a price that
did not reflect these improved fundamentals and was far below its October 2024 offer. In sum, Alcon swooped in at a low price when STAAR
was well along in fixing the problems that we believe had caused Alcon to back away from its previous offer at a much higher price. Given
time, Broadwood believes that STAAR could have quickly returned to significant revenue growth and substantial profitability, and then
conducted a robust sale process&mdash;the likely result of which would have been either a much higher bid from Alcon or success in pursuing
any of a number of other paths that would realize higher shareholder value.</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0 0 8pt; color: #111111">Fourth, an independent randomized clinical
trial &mdash; &ldquo;Measuring Outcomes of LASIK and EVO-ICL in Matched Populations (EVOlve)&rdquo; (NCT06700460) &mdash; is complete
and the results are expected to be published soon. This trial, which compares Alcon&rsquo;s LASIK platform to the EVO ICL, may have significant
implications for the competitive positioning of the EVO ICL relative to LASIK, and therefore to the long-term growth prospects of STAAR
and its strategic value to potential acquirers within the ophthalmic products industry. In its press release announcing the merger agreement,
Alcon referred to the EVO ICL as a product for moderate and high myopes, and also referenced in particular the rising number of high
myopes around the world. STAAR and its shareholders have long seen the opportunity for a further market share shift away from LASIK and
to the EVO ICL, driven in part by the growing body of clinical literature that supports the advantages of the EVO ICL for moderate and
some low myopes. Therefore, there is a clear misalignment in vision between Alcon and the owners of STAAR, its shareholders. Broadwood
is concerned that the timing of Alcon&rsquo;s actions may have been driven partly by the expected publication of this study.</P>

<P STYLE="color: #202020; font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt"><B><I>Broadwood&rsquo;s serious concerns about
the fairness and integrity of the sales process, in addition to the insufficient merger consideration, lead us to believe that the acquisition
is not in the best interest of STAAR&rsquo;s shareholders. Accordingly, Broadwood intends to vote against the acquisition and asks the
Board to immediately reconsider its recommendation thereof. </I></B></P>

<P STYLE="color: #111111; font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt">The statements above reflect only Broadwood&rsquo;s
current voting intent and is not a solicitation of proxies, nor a request to vote or withhold a proxy from any other shareholder. Broadwood
continues to evaluate its options and reserves all rights to take further action.</P>

<P STYLE="color: #202020; font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt"><B>Disclaimer </B></P>

<P STYLE="color: #202020; font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt">This press release does not constitute an offer
to sell or a solicitation of an offer to buy any of the securities described herein in any state to any person. This press release does
not recommend the purchase or sale of a security. There is no assurance or guarantee with respect to the prices at which any securities
of STAAR Surgical, Inc. will trade, and such securities may not trade at prices that may be implied herein. In addition, this press release
and the discussions and opinions herein are for general information only, and are not intended to provide investment advice.</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt; color: #202020">This press release contains forward-looking statements.
Forward-looking statements are statements that are not historical facts and may include projections and estimates and their underlying
assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations,
services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified
by the words &quot;expects&quot;, &quot;anticipates&quot;, &quot;believes&quot;, &quot;intends&quot;, &quot;estimates&quot;, &quot;plans&quot;,
&quot;will be&quot; and similar expressions. Although Broadwood believes that the expectations reflected in forward-looking statements
contained herein are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks
and uncertainties&mdash;many of which are difficult to predict and are generally beyond the control of Broadwood or STAAR&mdash;that could
cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information
and statements. In addition, the foregoing considerations and any other publicly stated risks and uncertainties should be read in conjunction
with the risks and cautionary statements discussed or identified in STAAR&rsquo;s public filings with the U.S. Securities and Exchange
Commission. The forward-looking statements speak only as of the date hereof and, other than as required by applicable law, Broadwood does
not undertake any obligation to update or revise any forward-looking information or statements. Certain information included in this material
is based on data obtained from sources considered to be reliable.</P>

<P STYLE="color: #202020; font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt">Broadwood also reserves the right to change the
opinions expressed herein and its intentions with respect to its investment in STAAR, and to take any actions with respect to its investment
in STAAR as it may deem appropriate, and disclaims any obligation to notify the market or any other party of any such changes or actions,
except as required by law.</P>

<P STYLE="color: #202020; font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt"><B>Contact: </B></P>

<P STYLE="color: #202020; font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">Neal Bradsher</P>

<P STYLE="color: #202020; font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">Broadwood Capital</P>

<P STYLE="color: purple; font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">neal@broadwoodcapital.com</P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 12pt; color: #202020">(212) 508-5735</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
